Sun-Ranbaxy near brand divestments ahead of combination?
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries and Ranbaxy Laboratories appear to be on course to seal the divestment of seven products ahead of their proposed combination in India.